Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
489.00
0.00 (0.00%)
Last updated: Dec 5, 2025, 9:00 AM CET
77.30%
Market Cap11.04B
Revenue (ttm)631.25M
Net Income (ttm)-246.42M
Shares Outn/a
EPS (ttm)-11.11
PE Ration/a
Forward PE124.81
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume0
Open489.00
Previous Close489.00
Day's Range489.00 - 489.00
52-Week Range237.50 - 518.20
Betan/a
RSI56.05
Earnings DateFeb 25, 2026

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.